- |||||||||| ketamine / Generic mfg.
Trial primary completion date: Treatment Resistant Depression (Pilot) (clinicaltrials.gov) - May 30, 2017 P=N/A, N=40, Recruiting, Phase classification: P=N/A --> P1 | N=30 --> 6 | Active, not recruiting --> Terminated; poor recruitment Trial primary completion date: Jun 2016 --> Jun 2018
- |||||||||| lorazepam / Generic mfg., diazepam / Generic mfg., alprazolam / Generic mfg.
Trial initiation date: Benzodiazepine-free Anesthetic for Reduction of Delirium (B-Free) (clinicaltrials.gov) - May 16, 2017 P1, N=480, Not yet recruiting, Trial primary completion date: Jun 2016 --> Jun 2018 Initiation date: May 2017 --> Sep 2017
- |||||||||| lorazepam / Generic mfg., ibuprofen / Generic mfg.
Trial primary completion date: Analgesia for Endometrial Scratching (clinicaltrials.gov) - May 9, 2017 P=N/A, N=150, Enrolling by invitation, Initiation date: May 2017 --> Sep 2017 Trial primary completion date: Mar 2017 --> Sep 2017
- |||||||||| Recentin (cediranib) / AstraZeneca
Trial primary completion date, Monotherapy, Metastases: Sunitinib or Cediranib for Alveolar Soft Part Sarcoma (clinicaltrials.gov) - May 4, 2017 P2, N=70, Recruiting, Trial primary completion date: Mar 2017 --> Sep 2017 Trial primary completion date: Apr 2017 --> Apr 2018
- |||||||||| gabapentin / Generic mfg.
Enrollment open: Gabapentin for Alcohol Withdrawal Syndrome (clinicaltrials.gov) - Feb 16, 2017 P4, N=400, Recruiting, Recruiting --> Completed Not yet recruiting --> Recruiting
- |||||||||| Onsolis (BEMA fentanyl) / Viatris, Collegium Pharma
Enrollment closed: Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (Liver AATD) (clinicaltrials.gov) - Nov 15, 2016 P1, N=109, Active, not recruiting, Recruiting --> Completed | Trial primary completion date: Apr 2017 --> Aug 2016 Recruiting --> Active, not recruiting
- |||||||||| Syntocinon Nasal Spray (oxytocin intranasal) / Vyera Pharma
Enrollment closed: Biological Basis of Individual Variation in Social Cooperation (clinicaltrials.gov) - Oct 10, 2016 P=N/A, N=750, Active, not recruiting, Active, not recruiting --> Completed Enrolling by invitation --> Active, not recruiting
- |||||||||| lorazepam / Generic mfg., haloperidol / Generic mfg.
Enrollment closed, Enrollment change, Metastases: Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer (clinicaltrials.gov) - Sep 16, 2016 P2, N=93, Active, not recruiting, Trial primary completion date: Oct 2016 --> Jan 2017 Recruiting --> Active, not recruiting | N=60 --> 93
- |||||||||| lorazepam / Generic mfg., topiramate / Generic mfg.
Trial completion, Trial primary completion date: Characterizing and Predicting Drug Effects on Cognition (clinicaltrials.gov) - Sep 15, 2016 P4, N=78, Completed, Recruiting --> Active, not recruiting | N=60 --> 93 Recruiting --> Completed | Trial primary completion date: May 2017 --> Aug 2016
- |||||||||| ondansetron intravenous / Generic mfg., lorazepam / Generic mfg., diazepam / Generic mfg.
Trial completion, Trial primary completion date: Treating Benign Paroxysmal Positional Vertigo (BPPV) in ED Patients (clinicaltrials.gov) - Sep 8, 2016 P=N/A, N=26, Completed, Recruiting --> Completed | Trial primary completion date: May 2017 --> Aug 2016 Enrolling by invitation --> Completed | Trial primary completion date: Mar 2013 --> Dec 2010
- |||||||||| lorazepam / Generic mfg., ibuprofen / Generic mfg.
New trial: Analgesia for Endometrial Scratching (clinicaltrials.gov) - Aug 11, 2016 P=N/A, N=150, Enrolling by invitation,
- |||||||||| Syntocinon Nasal Spray (oxytocin intranasal) / Vyera Pharma
Trial primary completion date: Biological Basis of Individual Variation in Social Cooperation (clinicaltrials.gov) - Jul 19, 2016 P=N/A, N=750, Enrolling by invitation, Recruiting --> Completed Trial primary completion date: Jun 2016 --> Sep 2016
- |||||||||| lorazepam / Generic mfg., midazolam hydrochloride / Generic mfg.
Trial completion: Lorazepam Sedation for Critically Ill Children (clinicaltrials.gov) - May 21, 2016 P2/3, N=179, Completed, Recruiting --> Completed Suspended --> Completed
- |||||||||| Recentin (cediranib) / AstraZeneca
Trial primary completion date, Monotherapy, Metastases: Sunitinib or Cediranib for Alveolar Soft Part Sarcoma (clinicaltrials.gov) - Mar 5, 2016 P2, N=70, Recruiting, N=200 --> 30 Trial primary completion date: Apr 2016 --> Apr 2017
- |||||||||| darigabat (CVL-865) / Cerevel Therap
Trial primary completion date: PF-06372865 in Subjects With Photosensitive Epilepsy (clinicaltrials.gov) - Feb 23, 2016 P2, N=8, Recruiting, Trial primary completion date: Apr 2016 --> Apr 2017 Trial primary completion date: Jul 2016 --> Nov 2016
- |||||||||| lorazepam / Generic mfg., haloperidol / Generic mfg.
Enrollment change, Trial primary completion date, Metastases: Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer (clinicaltrials.gov) - Feb 17, 2016 P2, N=60, Recruiting, Trial primary completion date: Jul 2016 --> Nov 2016 N=34 --> 60 | Trial primary completion date: Jan 2017 --> Jan 2018
- |||||||||| darigabat (CVL-865) / Cerevel Therap
Enrollment open: PF-06372865 in Subjects With Photosensitive Epilepsy (clinicaltrials.gov) - Feb 12, 2016 P2, N=8, Recruiting, N=34 --> 60 | Trial primary completion date: Jan 2017 --> Jan 2018 Not yet recruiting --> Recruiting
- |||||||||| Onsolis (BEMA fentanyl) / Viatris, Collegium Pharma
Trial primary completion date: Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (Liver AATD) (clinicaltrials.gov) - Jan 30, 2016 P1, N=100, Recruiting, N=150 --> 49 | Recruiting --> Terminated; DSMB recommendation for slow enrollment Trial primary completion date: Apr 2016 --> Apr 2017
- |||||||||| ketamine / Generic mfg.
Trial primary completion date: Treatment Resistant Depression (Pilot) (clinicaltrials.gov) - Nov 19, 2015 P=N/A, N=40, Recruiting, Trial primary completion date: Oct 2015 --> Sep 2016 Trial primary completion date: Dec 2015 --> Jun 2016
- |||||||||| Gralise (gabapentin) / Alvogen
Enrollment closed, Trial primary completion date: Stanford Accelerated Recovery Trial (START) (clinicaltrials.gov) - Aug 26, 2015 P3, N=560, Active, not recruiting, Trial primary completion date: Dec 2015 --> Jun 2016 Recruiting --> Active, not recruiting | Trial primary completion date: May 2014 --> Jul 2016
|